Further examinations indicated that Luteolin inhibited the migration and invasion of vascular endothelial cells of NSCLC by miR-133a-3p/PURB- mediated MAPK and PI3K/Akt pathways [74]. The gene discussed is PURB; the disease is non-small cell lung carcinoma.